Month: August 2022

TORONTO, Aug. 10, 2022 (GLOBE NEWSWIRE) — Dundee Corporation (TSX: DC.A) (the “Corporation” or “Dundee”) today announced its financial results for the three and six months ended June 30, 2022. All currency amounts in this press release are in Canadian dollars except as otherwise indicated. SECOND QUARTER 2022 RESULTSReported net loss from investments for the second quarter of 2022 of $52.9 million (2021 – income of $1.3 million). For the six months ended June 30, 2022, the Corporation reported a net loss from investments of $6.3 million (2021 – $9.6 million).Reported net loss attributable to owners of the Corporation for the second quarter of 2022 of $44.5 million (2021 – $11.5 million), or loss of $0.52 per share (2021 – $0.14 per share) including total non-cash items of $41.6 million (2021 – $15.0 million).For the six months...

THIS NEWS RELEASE IS NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES OF AMERICA TO UNITED STATES NEWSWIRE SERVICES OR UNITED STATES PERSONS CALGARY, Alberta, Aug. 10, 2022 (GLOBE NEWSWIRE) — Questerre Energy Corporation (“Questerre” or the “Company”) (TSX,OSE:QEC) reported today on its financial and operating results for the second quarter ended June 30, 2022. Michael Binnion, President, and Chief Executive Officer, commented, “During the quarter, three new Kakwa wells were brought on production. Leveraging the strong commodity prices, we recorded adjusted funds flow from operations of over $12 million for the period.” Commenting on Quebec, he added, “Protecting our legal rights is our top priority after the Government of Quebec announced its plans to enact Bill 21 and revoke our licenses without meaningful compensation....

CALGARY, Alberta, Aug. 10, 2022 (GLOBE NEWSWIRE) — Petrus Resources Ltd. (“Petrus” or the “Company”) (TSX: PRQ) is pleased to report financial and operating results as at and for the three and six months ended June 30, 2022. Q2 2022 HIGHLIGHTS:Production up 15% – Production was up 15% from 6,309 boe/d in the second quarter of 2021 to 7,280 boe/d in the second quarter of 2022 due to the new wells drilled in late 2021 and the strategic acquisition of Cardium assets located in Petrus’ Ferrier area that closed in March 2022.Funds flow(1) increased 188% – Generated funds flow of $23.2 million ($0.21 per share(2)) for the second quarter of 2022, 188% higher than funds flow of $8.1 million ($0.16 per share) for the second quarter of 2021.Operating netback(2) up 118% – Operating netback increased by 118% from $20.55/boe in...

EDMONTON, Alberta and NEW YORK, Aug. 10, 2022 (GLOBE NEWSWIRE) — Stantec (TSX, NYSE:STN), a global leader in sustainable design and engineering, today reported its results for the three and six month periods ended June 30, 2022. Unless otherwise indicated, financial figures are expressed in Canadian dollars and comparisons are to the prior period ended June 30, 2021. Stantec delivered another quarter of increased earnings on the strength of 22.9% net revenue growth. Consistent with the first quarter of this year, every regional and business operating unit delivered organic net revenue growth1 and recent acquisitions generated double-digit growth. Earnings were further enhanced by an 80 basis point increase in project margin. Backlog also continued to grow, increasing organically by 13% since year end 2021 and now stands at a record...

– Announced positive topline Phase 1 results of RT-102 for the treatment of osteoporosis – – Anticipate initiating an additional Phase 1 clinical trial in 2H 2022 – – Capitalized to fund operations into mid-2024 – SAN JOSE, Calif., Aug. 10, 2022 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics”, “the Company” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today reported financial results for the second quarter ended June 30, 2022 and provided a corporate update. “Continuing the momentum built in the year since going public, today we announced topline results from the single-ascending portion of our Phase 1 clinical trial with RT-102, the RaniPill™ capsule containing our proprietary formulation...

Second Quarter Net Revenue of $2.9 Million, a 27% Year-Over-Year Increase;Active Customer Sites Climb 21% to New Record SOUTH ORANGE, NJ, Aug. 10, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced financial results for the second quarter ended June 30, 2022. Financial HighlightsWater Filtration Business Segment Highlights*Net revenue of $2.8 million, an increase of 30% Net loss of $0.6 million, compared to $0.9 million Adjusted EBITDA of ($0.2 million), compared with ($0.5 million)Consolidated Highlights*Net revenue of $2.9 million, an increase of 27% Net loss of $1.1 million, compared to $1.1 million Adjusted EBITDA of ($0.7 million), compared to ($0.8...